Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized, double-blind, crossover study.

Sathyapalan T, Manuchehri AM, Thatcher NJ, Rigby AS, Chapman T, Kilpatrick ES, Atkin SL.

J Clin Endocrinol Metab. 2011 May;96(5):1442-9. doi: 10.1210/jc.2010-2255. Epub 2011 Feb 16.

PMID:
21325465
2.

Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes.

Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL.

Diabetes Care. 2002 Oct;25(10):1709-14.

PMID:
12351466
3.
4.

Different effects of fenofibrate on metabolic and cardiovascular risk factors in mixed dyslipidemic women with normal thyroid function and subclinical hypothyroidism.

Krysiak R, Gilowski W, Szkrobka W, Okopien B.

Cardiovasc Ther. 2014 Dec;32(6):264-9. doi: 10.1111/1755-5922.12095.

PMID:
25290818
5.

Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.

Hall WL, Vafeiadou K, Hallund J, Bugel S, Reimann M, Koebnick C, Zunft HJ, Ferrari M, Branca F, Dadd T, Talbot D, Powell J, Minihane AM, Cassidy A, Nilsson M, Dahlman-Wright K, Gustafsson JA, Williams CM.

Am J Clin Nutr. 2006 Mar;83(3):592-600.

6.

[The effects of phytoestrogen on blood pressure and lipids in healthy volunteers].

Liang YL, Teede H, Dalais F, McGrath BP.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Aug;34(8):726-9. Chinese.

PMID:
17081400
7.

Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women.

Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP.

J Clin Endocrinol Metab. 2001 Jul;86(7):3053-60.

PMID:
11443167
8.
9.

Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women.

Teas J, Hurley TG, Hebert JR, Franke AA, Sepkovic DW, Kurzer MS.

J Nutr. 2009 May;139(5):939-44. doi: 10.3945/jn.108.100834. Epub 2009 Mar 25. Erratum in: J Nutr. 2009 Sep;139(9):1779.

10.

Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects.

Hermansen K, Hansen B, Jacobsen R, Clausen P, Dalgaard M, Dinesen B, Holst JJ, Pedersen E, Astrup A.

Eur J Clin Nutr. 2005 Jul;59(7):843-50.

PMID:
15900307
11.

Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea.

Jung CH, Sung KC, Shin HS, Rhee EJ, Lee WY, Kim BS, Kang JH, Kim H, Kim SW, Lee MH, Park JR, Kim SW.

Korean J Intern Med. 2003 Sep;18(3):146-53.

12.

The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial.

Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU.

J Clin Endocrinol Metab. 2007 May;92(5):1715-23. Epub 2007 Feb 13.

PMID:
17299073
13.

Effects of dietary phytoestrogens in postmenopausal women.

Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R, Strauss BJ.

Climacteric. 1998 Jun;1(2):124-9.

PMID:
11907915
14.

Short-term phytoestrogen supplementation alters insulin-like growth factor profile but not lipid or antioxidant status.

Woodside JV, Campbell MJ, Denholm EE, Newton L, Honour JW, Morton MS, Young IS, Leathem AJ.

J Nutr Biochem. 2006 Mar;17(3):211-5. Epub 2005 Aug 31.

PMID:
16169206
15.

Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study.

Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK.

J Clin Endocrinol Metab. 2013 May;98(5):1982-90. doi: 10.1210/jc.2012-4107. Epub 2013 Mar 28.

PMID:
23539727
16.
17.

A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium.

Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM.

J Soc Gynecol Investig. 2002 Jul-Aug;9(4):238-42.

PMID:
12113884
18.

Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women.

Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Amato P, Young RL, Barnes S, Konzelmann KL, Fischer JG, Ellis KJ, Shypailo RJ, Fraley JK, Smith EO, Wong WW.

Am J Clin Nutr. 2011 Feb;93(2):356-67. doi: 10.3945/ajcn.110.008359. Epub 2010 Dec 22.

19.

Effects of black soy peptide supplementation on blood pressure and oxidative stress: a randomized controlled trial.

Kwak JH, Kim M, Lee E, Lee SH, Ahn CW, Lee JH.

Hypertens Res. 2013 Dec;36(12):1060-6. doi: 10.1038/hr.2013.79. Epub 2013 Aug 8.

PMID:
23924691
20.

Cardiovascular risk factors in children with long-standing untreated idiopathic subclinical hypothyroidism.

Cerbone M, Capalbo D, Wasniewska M, Mattace Raso G, Alfano S, Meli R, De Luca F, Salerno M.

J Clin Endocrinol Metab. 2014 Aug;99(8):2697-703. doi: 10.1210/jc.2014-1761. Epub 2014 May 19.

PMID:
24840815

Supplemental Content

Support Center